Lung Cancer Research

Closing the Funding Gap in Cancer Research

Lung cancer claims more lives each year than breast, colon and prostate cancers combined, yet lung cancer receives disproportionately less government funding per cancer death than other types of cancer. This means that private funding for research focused on lung cancer is vital to saving lives.

Learn more about the 2017/2018 Tona Vives Research Award Winners – Dr. Stefani Spranger (MIT), Drs. Laura Stabile and Timothy Burns (University of Pittsburgh), ABOH Research Fellows: Dr. Jun-Chieh (James) Tsay (NYU), Larry Benjamin Early Detection Award and past recipients: Dr. Kamesh Bikkavilli (UIC) and Dr. Manish Patel (Masonic Cancer Center, U of M).

A Breath of Hope Lung Foundation (ABOH) raises funds to promote lung cancer awareness, support patients and families, and fund U.S. lung cancer research. The primary focus of the ABOH Research Program is to retain promising young researchers in the field through competitive $150,000 awards. Retaining talent in the field of lung cancer research is critical to changing outcomes.

ABOH’s “Named Research Grants” enable donors to fund part or all of a research fellowship in their name or in memory or honor of a loved one.

Please join our lung cancer research efforts, your donation will lead to improved late stage treatments and improved early detection methods.

Research Facts & Underfunding

  • Approximately 50% of new cases are non-smokers or former smokers, many of whom quit decades ago. One in five women and one in twelve men diagnosed with lung cancer have never smoked.
  • 160,000 Americans die annually, including 2500 Minnesotans. More than 226,000 people are diagnosed with lung and bronchus cancer in the US each year.
  • Lung cancer kills nearly twice as many women as breast cancer. In recent years, the National Cancer Institute estimated that our government spent over $14,000 per breast cancer death for research, and $1,700 per lung cancer death.
  • Lack of funding drives talented young researchers away from lung cancer, despite their interest and commitment.
  • Lung cancer kills more people than breast, prostate and colon cancers combined, yet receives less funding than each (see graph below).

2016 Spending vs. Deaths Chart